Plum Polyphenols Inhibit Colorectal Aberrant Crypt Foci Formation in Rats: Potential Role of the MiR-143/protein Kinase B/mammalian Target of Rapamycin Axis
Overview
Authors
Affiliations
The nutritional prevention of aberrant crypt foci by polyphenols may be a crucial step to dietary cancer prevention. The objective of this study was to determine the underlying mechanisms that contribute to the anti-inflammatory and antitumorigenic properties of plum (Prunus salicina L.) polyphenols, including chlorogenic acid and neochlorogenic acid, in azoxymethane (AOM)-treated rats. The hypothesis was that plum polyphenolics suppress AOM-induced aberrant crypt foci formation through alterations in the protein kinase B (AKT)/mammalian target of rapamycin (mTOR) pathway and relative micro-RNA expressions. Sprague-Dawley rats (n=10/group) received plum beverage (1346mg gallic acid equivalents/L) or a control beverage ad libitum for 10 weeks with subcutaneous injections of AOM (15mg/kg) at weeks 2 and 3. Results show that the consumption of the plum beverage decreased the number of dysplastic aberrant crypt foci by 48% (P<.05) and lowered proliferation of mucosal cells by 24% (P<.05). The plum beverage decreased the activity of glutathione peroxidase, superoxide dismutase, and catalase in mucosal scrapings, as well as the superoxide dismutase activity in serum. The results were accompanied by a down-regulation of proinflammatory enzymes nuclear factor κB, nitric oxide synthase, cyclooxygenase-2, and vascular cell adhesion molecule 1 messenger RNA. Plum inhibited the expression of AKT and mTOR messenger RNA, phosphorylated AKT, mTOR, and hypoxia-inducible factor-1α protein levels, and the ratio of the phosphorylated/total protein expression of mTOR. Also, the plum beverage increased the expression of miR-143, which is involved in the regulation of AKT. These results suggest that plum polyphenols may exhibit a chemopreventive potential against colon carcinogenesis by impacting the AKT/mTOR pathway and miR-143.
cakar U, colovic M, Milenkovic D, Pagnacco M, Maksimovic J, Krstic D Antioxidants (Basel). 2025; 14(2).
PMID: 40002342 PMC: 11851380. DOI: 10.3390/antiox14020155.
Natural compounds as regulators of miRNAs: exploring a new avenue for treating colorectal cancer.
Doghish A, Mageed S, Mohammed O, Abdel-Reheim M, Zaki M, Mohamed A Funct Integr Genomics. 2025; 25(1):42.
PMID: 39982533 DOI: 10.1007/s10142-025-01547-8.
A Comprehensive View on the Impact of Chlorogenic Acids on Colorectal Cancer.
Neamtu A, Maghiar T, Turcus V, Maghiar P, Capraru A, Lazar B Curr Issues Mol Biol. 2024; 46(7):6783-6804.
PMID: 39057047 PMC: 11276415. DOI: 10.3390/cimb46070405.
Polyphenols: Role in Modulating Immune Function and Obesity.
Mamun M, Rakib A, Mandal M, Kumar S, Singla B, Singh U Biomolecules. 2024; 14(2).
PMID: 38397458 PMC: 10887194. DOI: 10.3390/biom14020221.
Taibi A, Lofft Z, Laytouni-Imbriaco B, Comelli E Front Nutr. 2023; 10:1092342.
PMID: 37287997 PMC: 10242055. DOI: 10.3389/fnut.2023.1092342.